Multiple myeloma showing increased accumulation of Tc-99m hexamethylpropylene amine oxime on brain SPECT

Clin Nucl Med. 2000 Jun;25(6):495-6. doi: 10.1097/00003072-200006000-00030.

Abstract

The authors report a case of multiple myeloma with increased accumulation of Tc-99m hexamethylpropylene amine oxime (HMPAO) on brain SPECT. Tc-99m HMPAO is a lipophilic compound that freely passes through the intact blood-brain barrier and cell membrane and is rapidly converted to a hydrophilic form by glutathione and then retained in the neuron for several hours. In general, Tc-99m HMPAO shows decreased accumulation in brain tumors. However, some reports of increased accumulation in brain tumors, such as meningioma, glioblastoma multiforme, high-grade astrocytoma, pituitary adenoma, and multiple myeloma, have been published. The Tc-99m HMPAO uptake in these tumors has been attributed to tumor blood flow or glutathione contents within the tumor. With regard to uptake to Tc-99m HMPAO in multiple myeloma, the tumor size is considered to be an additional factor.

Publication types

  • Case Reports

MeSH terms

  • Blood-Brain Barrier
  • Brain Neoplasms / blood supply
  • Brain Neoplasms / diagnostic imaging*
  • Brain Neoplasms / pathology
  • Female
  • Humans
  • Middle Aged
  • Multiple Myeloma / diagnostic imaging*
  • Multiple Myeloma / pathology
  • Radiopharmaceuticals*
  • Technetium Tc 99m Exametazime*
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Exametazime